Abstract
Background
The intraoperative application of mitomycin c for primary trabeculectomy is associated with potentially sight-threatening side-effects. This study was performed to evaluate the pressure-lowering effect of postoperative application of mitomycin c for primary trabeculectomy and to evaluate the complications of this new technique.
Materials and methods
A randomized, prospective clinical trial with 52 consecutive patients scheduled for glaucoma surgery in one large surgical center was performed. Patients underwent routine trabeculectomy. In group 1, mitomycin c (0.05 mg/ml) was applied topically to the filtering bleb for 5 min on the 3 days after surgery (postoperative application). In group 2, no mitomycin c was applied (controls). The IOP values, visual acuity, number of antiglaucomatous medications and complications were evaluated.
Results
Follow-up was evaluated up to 24 months for all patients. The mean intraocular pressure decreased from 31.1 to 15.4 mmHg in group 1 and from 24.8 to 15.6 mmHg in group 2 (P=0.79; t-test). The average number of medications decreased from 2.5 and 2.4 to 0.4 and 0.6 (P=0.53; t-test) in groups 1 and 2, respectively. No cases of hypotony maculopathy occurred. An individual decrease of more than 25% of the IOP was present in 84.6% in group 1 and in 53.8% in group 2 (P<0.017). Survival analysis for eyes with a complete surgical success revealed a better outcome of eyes in group 1 as compared to the eyes in group 2 (P<0.013; log-rank test).
Conclusions
To our knowledge, this is the first prospective, randomized clinical trial to evaluate the efficacy of postoperative mitomycin c application in primary trabeculectomy. The application of mitomycin significantly reduced the IOP while not increasing the rate of complications.
Similar content being viewed by others
References
Bindlish R, Condon GP, Schlosser JD, D’Antonio J, Lauer KB, Lehrer R (2002) Efficacy and safety of mitomycin-c in primary trabeculectomy. five-year follow-up. Ophthalmology 109:1336–1342
Cairns JE (1968) Trabeculectomy: preliminary report of a new method. Am J Ophthalmol 66:673–679
Chen CW, Huang HT, Bair JS, Lee CC (1990) Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol 6:175–182
Costa VP, Moster MR, Wilson RP et al (1993) Effects of topical mitomycin C on primary trabeculectomies and combined procedures. Br J Ophthalmol 77:693–697
Gandolfi SA, Vecchi M, Braccio L (1995) Decrease of intraocular pressure after subconjunctival injection of mitomycin in human glaucoma. Arch Ophthalmol 113:582–585
Karp CL, Higginbotham EJ, Griffin EO (1994) Adjunctive use of transconjunctival mitomycin-C in ab externo diode laser sclerostomy surgery in rabbits. Ophthalmic Surg 25:22–27
Katz GJ, Higginbotham EJ, Lichter PR et al (1995) Mitomycin C versus 5–fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology 102:1263–1269
Kim YY, Sexton RM, Shin DH et al (1998) Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. Am J Ophthalmol 126:755–762
Kitazawa Y, Suemori-Matsushita H, Yamamoto T, Kawase K (1993) Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 100:1624–1628
Kupin TH, Juzych MS, Shin DH et al (1995) Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am J Ophthalmol 119:30–39
Matsuo H, Tomidokoro A, Suzuki Y, Shirato S, Araie M (2002) Late-onset transconjunctival oozing and point leak of aqueous humor from filtering bleb after trabeculectomy. Am J Ophthalmol 133:456–462
Mermoud A, Salmon JF, Murray AND (1993) Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol 116:72–78
Mietz H, Addicks K, Diestelhorst M, Krieglstein GK (1994) Extraocular application of mitomycin C in a rabbit model: cytotoxic effects on the ciliary body and epithelium. Ophthalmic Surg 25:240–244
Mietz H, Brunner R, Addicks K, Krieglstein GK (1993) Histopathology of an avascular filtering bleb after trabeculectomy with mitomycin-C. J Glaucoma 2: 266–270
Mietz H, Raschka B, Krieglstein GK (1999) Risk factors of trabeculectomies performed without antimetabolites. Br J Ophthalmol 83:814–821
Mietz H, Jacobi PC, Krieglstein GK (2000) Postoperative application of mitomycin for trabeculectomies. Arch Ophthalmol 118:1341–1348
Nuyts RMMA, Felten PC, Pels E et al (1994) Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am J Ophthalmol 118:225–237
Palmer SS (1991) Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 98:317–321
Prata JA Jr, Minckler DS, Baerveldt G et al (1994) Site of mitomycin-C application during trabeculectomy. J Glaucoma 3:296–301
Schubert HD (1996) Postsurgical hypotony: relationship to fistulization, inflammation, chorioretinal lesions, and the vitreous. Surv Ophthalmol 41:97–125
Shields MB, Scroggs MW, Sloop CM, Simmons RB (1993) Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin c. Am J Ophthalmol 116:673–683
Suner IJ, Greenfield DS, Miller MP et al (1997) Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology 104:207–214; discussion 214–215
Susanna R, Costa VP, Malta RFS, Barboza WL, Vasconcellos JPC (2001) Intraoperative mitomycin-c without conjunctival and tenon’s touch in primary trabeculectomy. Ophthlamology 108:1039–1042
The Fluorouracil Filtering Surgery Study Group (1996) Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 121:349–366
Tressler CS, Cyrlin MN, Rosenshein JS, Fazio R (1996) Subconjunctival versus intrascleral mitomycin-C in trabeculectomy. Ophthalmic Surg Lasers 27:661–666
Uchida S, Suzuki Y, Araie M, Shigeeda T, Hara T, Shirato S (2001) Long-term follow-up of initial 5-fluorouracil trabeculectomy inb primary open-angle glaucoma in Japanese patients. J Glaucoma 10:458–465
Vijaya L, Mukhesh BN, Shantha B, Ramalingam S, Sathi Devi AV (2000) Comparison of low-dose intraoperative mitomycin-c vs 5-fluorouracil in primary glaucoma surgery. a pilot study. Ophthalmic Surg Lasers 31:24–30
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mietz, H., Krieglstein, G.K. Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial. Graefe's Arch Clin Exp Ophthalmo 244, 1429–1436 (2006). https://doi.org/10.1007/s00417-005-0217-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-005-0217-y